Osteoporosis treatment rates after hip fracture 2011–2019 in Hawaii: Undertreatment of men after hip fractures

• Main Authors: Luke Taylor, Chieko Kimata, Andrea M. Siu, Samantha N. Andrews, Prashant Purohit, Melissa Yamauchi, Andras Bratincsak, Russell Woo, Cass K. Nakasone, Sian Yik Lim
• Format: Article
• Language: English
• Published: Elsevier 2021-09-01
• Series: Osteoporosis and Sarcopenia
• Subjects: Hip fracture; Hospitalization; Osteoporosis
• Online Access: http://www.sciencedirect.com/science/article/pii/S2405525521000595

Objectives: To investigate trends of osteoporosis treatment rates, and factors affecting osteoporosis treatment after hip fracture admission within a single health care system in Hawaii. Methods: A retrospective chart review was conducted of patients aged 50 years or older and hospitalized for hip fractures between January 1, 2011 and December 31, 2019 at Hawaii Pacific Health, a large health care system in Hawaii. We collected data on basic demographics and osteoporosis medication prescription from electronic medical records. We evaluated trends of osteoporosis treatment rates and performed logistic regression to determine factors associated with osteoporosis treatment. Results: The mean for treatment rates for osteoporosis from 2011 to 2019 was 17.2% (range 8.8%–26.0%). From 2011 to 2019 there was a small increase in treatment rates from 16.3% in 2011 to 24.1% in 2019. Men were less likely to receive osteoporosis treatment after admission for hip fracture. Patients discharged to a facility were more likely to receive osteoporosis treatment. As compared to women, men who had a hip fracture were less likely to receive dual-energy X-ray absorptiometry scan, and osteoporosis medication before hip fracture admission. Conclusions: The use of osteoporosis medication for secondary prevention after admission for hip fracture in Hawaii from 2011 to 2019 was low. However, there was a small increase in treatment rates from 2011 to 2019. Disparities in treatment of osteoporosis after hip fracture were noted in men. Significant work is needed to increase treatment rates further, and to address the disparity in osteoporosis treatment between men and women.